AT&T Inc. 5.350% Global Notes due 2066 (TBB)

Cost of Revenue

$6.34B

Quarterly · Period ending: · USD

TBB logo

TBB Cost of Revenue

Latest reported$6.34B
TBB Quarterly Cost of Revenue ($0.00 → $6.34B)
High-resolution chart · PNG

TBB cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AT&T Inc. 5.350% Global Notes due 2066 Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
6,344,000,000
6,306,000,000
6,261,000,000
19,946,000,000
6,351,000,000
12,150,000,000
6,339,000,000
-18,173,000,000
11,630,000,000
11,442,000,000
11,954,000,000
18,677,000,000
12,054,000,000
11,827,000,000
12,331,000,000
13,571,000,000
12,201,000,000
12,341,000,000
17,557,000,000
19,795,000,000
17,826,000,000
21,099,000,000
21,087,000,000
22,910,000,000
19,839,000,000
17,983,000,000
19,281,000,000
22,736,000,000
20,154,000,000
20,512,000,000
20,739,000,000
23,309,000,000
20,706,000,000
17,458,000,000
17,946,000,000
22,332,000,000
18,906,000,000
18,254,000,000
17,887,000,000
21,119,000,000
18,890,000,000
18,475,000,000
18,400,000,000
19,691,000,000
17,796,000,000
15,140,000,000
14,581,000,000
18,537,000,000
14,541,000,000
14,212,000,000
13,321,000,000
12,237,000,000
13,403,000,000
13,270,000,000
12,554,000,000
17,552,000,000
12,718,000,000
12,369,000,000
12,913,000,000
17,474,000,000
13,165,000,000
13,332,000,000
13,403,000,000
13,897,000,000
13,519,000,000
12,381,000,000
12,329,000,000
12,800,000,000
12,885,000,000
12,478,000,000
12,242,000,000
12,923,000,000
13,070,000,000
11,900,000,000
11,775,000,000
11,734,000,000
11,591,000,000
11,478,000,000
11,252,000,000
6,708,000,000
6,664,000,000
6,928,000,000
7,128,000,000
6,014,000,000
4,352,000,000
4,347,000,000
4,397,000,000
4,580,000,000
4,284,000,000
4,305,000,000
4,227,000,000
4,333,000,000
4,244,000,000
4,035,000,000
4,041,000,000
7,140,000,000
6,287,000,000
6,430,000,000
6,080,000,000
7,318,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.